Dr. Grant Patrick Redrow, MD

Dr. Redrow practices at Gulf Coast Urology in Houston, Texas.

Dr. Redrow's NPI, 1316293152, was assigned on July 30, 2012. Dr. Redrow graduated from Joe R. & Teresa Lozano Long School of Medicine in 2012. Dr. Redrow holds Texas license R7095.

Dr. Redrow's primary practice is Gulf Coast Urology, at 1315 St Joseph Pkwy, Houston, TX 77002 in Harris County. The practice phone is (713) 650-1502.

Dr. Redrow's primary practice is Gulf Coast Urology in Houston, Texas. Dr. Redrow is also affiliated with Memorial Hermann Greater Heights Hospital. The medical group on file is Gulf Coast Urology. Dmand AI also links Dr. Redrow to 3 more hospitals, 1 physician office and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Redrow practices, 6 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Redrow's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Redrow is board certified in urology by the American Board of Urology. Dmand AI has Dr. Redrow's licenses on file in 4 states: Texas, Nevada, Ohio and California.

Dmand AI lists bladder disease, enlarged prostate, enlarged prostate transurethral surgery (TURP), erectile dysfunction, kidney cysts, kidney removal surgery, kidney stone disease and prostate cancer among the conditions Dr. Redrow treats.

CMS data shows 617 Medicare services from Dr. Redrow across 8 procedure codes in 2024, for 172 Medicare patients. Medicare paid $33,325 for them. Every service was in an office.

CMS counts 172 Medicare patients who saw Dr. Redrow in 2024. The largest group is 65 to 74, with 78 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.35, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Redrow's median patient age at 67, with 17% women.

In 2024, Dr. Redrow wrote 1,212 Medicare Part D claims for 406 patients. 94% of them were for generic drugs. CMS names the drug for 1,115 of them, across 23 drugs with 11 or more claims each, at $58,024 in total drug cost. In 2023, CMS named 753 claims across 20 drugs.

Dr. Redrow accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Redrow as offering telehealth. CMS counts 13 procedures of prostate resection by Dr. Redrow, more than 67% of the clinicians it reports for that procedure.

Dmand AI links 6 papers to Dr. Redrow, published from 2014 to 2016. 2014 was the busiest year, with 2. Dr. Redrow's most frequent co-authors are Chad M. Thompson, MD, Antonio Anzueto, MD and Jonathan Andrew Coleman, MD.

CMS Open Payments shows 111 general payments to Dr. Redrow from 37 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 48% of the total. Intuitive Surgical, Inc. paid the most, $4,012.

Dmand AI lists 1 award for Dr. Redrow, most recently Alpha Omega Alpha Honor Society in 2012.

Dr. Redrow graduated from Joe R. & Teresa Lozano Long School of Medicine in 2012.

Dr. Redrow is in network with 25 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 15. Check the plan with the practice before a visit.